US Stock MarketDetailed Quotes
ONVO Organovo Holdings
- 0.960
- +0.050+5.49%
Close May 8 16:00 ET
10.97MMarket Cap-444P/E (TTM)
0.990High0.890Low306.36KVolume0.950Open0.910Pre Close287.81KTurnover2.73%Turnover RatioLossP/E (Static)11.43MShares2.05052wk High1.77P/B10.78MFloat Cap0.89052wk Low--Dividend TTM11.23MShs Float273.000Historical High--Div YieldTTM10.99%Amplitude0.890Historical Low0.939Avg Price1Lot Size
About Organovo Holdings Company
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolONVO
Company NameOrganovo Holdings
Listing DateJul 11, 2013
Founded2012
CEOMr. Keith Murphy
MarketNASDAQ
Employees24
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address11555 Sorrento Valley Road,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-224-1000
Websitehttp://www.organovo.com
Company Executives
- Name
- Position
- Salary
- Thomas P. Hess
- President, Principal Accounting Officer and Chief Financial Officer
- --
- Keith Murphy
- Executive Chairman of the Board and Principal Executive Officer
- 108.71K
- Vaidehi Joshi
- Director and Director of Discovery Biology
- 121.40K
- Alison Tjosvold Milhous
- Independent Director
- 165.00K
- Douglas Jay Cohen
- Lead Independent Director
- 135.00K
- David Gobel
- Independent Director
- 135.00K
- Adam K. Stern
- Independent Director
- 126.90K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg